Genetics

Scientists identify genetic risk factors for opioid use disorder

A new human genomics study led by Yale scientists has identified genetic risk factors for opioid use disorder (OUD) and related substance use disorders according to a new large-scale genome-wide association study—increasing ...

Medications

Global disparities persist in opioid painkiller access

Global opioid sales increased by an estimated 4% annually from 2015 to 2019, but massive disparities in access to essential pain relief medications persist between countries, finds a study led by UCL researchers.

page 12 from 40